Join the club for FREE to access the whole archive and other member benefits.

Deep Pharma Intelligence

AI company for drug discovery, biomarker development and advanced R&D landscape

Deep Pharma Intelligence (DPI) is a leading UK-based strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, Biotech, and Healthcare Tech industries.

Deep Pharma Intelligence is a joint venture created by Deep Knowledge Analytics Pharma Division and BPT Analytics (BiopharmaTrend) -- two highly specialized think tanks in the area of biotech innovation profiling, business intelligence, and biotech investment advisory. The company is dedicated to producing powerful data mining and visualization systems, interactive analytics tools, and industry reports offering deep technical insights, business intelligence, and strategic guidance in the high growth and significant opportunity areas of the pharmaceutical industry, including artificial intelligence (AI) in drug discovery, emerging therapeutic targets and drug modalities, new therapies and technologies, promising startups, and more.

Visit website:





Details last updated 27-Jun-2021

Deep Pharma Intelligence Creations

AI in Drug Discovery, Biomarker Development and Advanced R&D


Online webinar about Artificial Intelligence in Drug Discovery organized by Deep Pharma Intelligence (FREE)

The Landscape of Cancer Vaccines and Research Platforms: The Cutting Edge


Findings from a unique market study revealing R&D platforms for developing therapeutic cancer vaccines

People at Deep Pharma Intelligence

Andrii Buvailo

Co-founder and Director at Deep Pharma Intelligence

Topics mentioned on this page:
AI in Healthcare